查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1453903

2030 年肺动脉瓣置换市场预测：按瓣膜类型、手术类型、应用、最终用户和地区进行的全球分析

Pulmonary Valve Replacement Market Forecasts to 2030 - Global Analysis By Valve Type, Procedure Type, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球肺动脉瓣置换市场规模为 12 亿美元，预计在预测期内复合年增长率为 7.1%，到 2030 年将达到 20 亿美元。

肺动脉瓣置换术（PVR）是一种旨在替换心臟中有缺陷或损坏的肺动脉瓣的外科手术。肺动脉瓣调节从心臟右心室流向肺动脉的血流，促进肺部血液氧合。外科医生通常使用机械或生物人工瓣膜来恢復正常的心臟功能。 PVR 可缓解呼吸急促、胸痛和疲劳等症状，改善整体心臟健康和生活品质。术后护理包括监测併发症和心臟康復，以支持康復和长期健康。

医疗保健支出增加

随着医疗保健支出的增加，特别是在新兴经济体和已开发国家，获得专业心臟护理的机会也在增加。这些基础设施的改进将使医疗保健提供者能够为更多患者提供更广泛的治疗选择。此外，医疗保健支出的增加通常与保险覆盖范围和报销政策的改善有关，从而减少患者的财务障碍。

高成本

手术的复杂性和侵入性是导致肺动脉瓣置换术高成本的两个主要因素。这些因素影响手术的总成本，包括术前评估、术后照护和后续观察。此外，用于肺动脉瓣置换的材料（例如人工瓣膜和导管）可能很昂贵，这进一步增加了手术成本。

技术进步

人工瓣膜设计和材料的进步有助于提高肺动脉瓣置换术的寿命、耐用性和生物相容性。这些创新带来更好的临床结果并降低瓣膜关闭不全率，从而提高患者满意度并减少再次手术的需要。此外，3D 超音波心动图和心臟磁振造影(MRI) 等影像技术的进步正在增强术前规划并推动该市场的成长。

缺乏意识

对肺动脉瓣疾病的症状和后果认识不足可能会延误诊断和干预，导致患者预后不良。医疗保健提供者也缺乏对技术和工艺最新进展的透彻了解，这可能导致患者护理不佳和适当治疗方法的利用不足。此外，患者及其家人可能对外科手术有误解和恐惧，这可能会阻碍市场规模。

COVID-19 的影响

COVID-19 的爆发对肺动脉瓣置换市场产生了重大影响。随着世界各地的医疗系统投入资源对抗这场流行病，包括肺动脉瓣置换术在内的选择性手术被推迟或取消。这导致专门从事心臟介入治疗的製造商和医疗机构的手术数量和收益下降。此外，患者因担心接触病毒而不愿寻求非紧急护理，进一步减少了肺动脉瓣置换术的需求。

组织工程肺动脉瓣领域预计在预测期内成为最大

据估计，组织工程肺动脉瓣段占最大份额。这些瓣膜旨在模仿天然肺动脉瓣的结构和功能，为肺动脉瓣功能障碍患者提供了一个有前景的解决方案。组织工程肺动脉瓣通常是透过将细胞接种到生物分解性的支架上来製造，从而允许生物组织生长。此外，组织工程瓣膜在长期功能和动态性能方面显示出可喜的结果，逐渐推动了该领域的成长。

经导管肺动脉瓣置换术（TPVR）领域预计在预测期内复合年增长率最高

经导管肺动脉瓣置换术（TPVR）领域预计在预测期内复合年增长率最高，因为它是一种使用导管治疗的微创肺动脉瓣置换术。这种方法对于患有先天性心臟病、肺动脉瓣狭窄和逆流的患者特别有益。此外，与传统的外科手术相比，TPVR 手术在安全性、有效性和患者復健方面显示出优异的结果，这正在推动这一领域的扩张。

比最大的地区

由于先天性心臟疾病和瓣膜性心臟病的盛行率不断增加，北美在估计期间占据了最大的市场占有率。该地区是Medtronic)、雅培实验室 (Abbott Laboratories) 和波士顿科学 (Boston Scientific) 等大公司的所在地。此外，旨在改善心血管保健和促进医学研究的政府措施也在推动市场成长方面发挥重要作用。

复合年增长率最高的地区：

由于医疗技术的显着进步和健全的医疗保健系统，预计欧洲在预测期内的复合年增长率最高。德国、法国、英国和义大利等国家对该地区的市场成长做出了重大贡献。此外，欧洲拥有强大的法律规范，支持医疗创新、确保新型肺动脉瓣置换技术的安全性和有效性、促进竞争并促进该领域的进步。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球肺动脉瓣置换市场：依瓣膜类型

  • 组织工程肺动脉瓣
  • 生物人工肺瓣膜
  • 同种异体肺动脉瓣
  • 机械性肺动脉瓣
  • 其他阀门类型

第六章全球肺动脉瓣置换市场：依手术类型

  • 经导管肺动脉瓣置换术（TPVR）
  • 肺动脉瓣置换术（心臟直视手术）
  • 机器人辅助肺动脉瓣置换术
  • 罗斯手术
  • 瓣膜切开术
  • 其他治疗类型

第七章全球肺动脉瓣置换市场：依应用分类

  • 肺动脉狭窄
  • 瓣膜功能障碍
  • 先天性心臟缺陷
  • 肺逆流
  • 其他用途

第八章全球肺动脉瓣置换市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 心臟专科诊所
  • 其他最终用户

第九章全球肺动脉瓣置换市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Edwards Lifesciences
  • Medtronic
  • Terumo Corporation
  • CryoLife, Inc
  • SynCardia Systems, Inc.
  • Abbott Laboratories
  • Merit Medical Systems
  • LivaNova PLC
  • Micro Interventional Devices, Inc.
  • Boston Scientific
  • Braile Biomedica
  • JenaValve Technology, Inc.
  • B. Braun Melsungen AG
  • Medistim
  • CardioMech AS
Product Code: SMRC25455

According to Stratistics MRC, the Global Pulmonary Valve Replacement Market is accounted for $1.2 billion in 2023 and is expected to reach $2.0 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Pulmonary valve replacement (PVR) is a surgical procedure aimed at replacing a defective or damaged pulmonary valve in the heart. The pulmonary valve regulates blood flow from the heart's right ventricle to the pulmonary artery, facilitating oxygenation of blood in the lungs. Surgeons typically use either mechanical or biological prosthetic valves to restore proper cardiac function. PVR can alleviate symptoms like shortness of breath, chest pain, and fatigue, improving overall heart health and quality of life. Post-operative care involves monitoring for complications and cardiac rehabilitation to support recovery and long-term well-being.

Market Dynamics:

Driver:

Increasing healthcare expenditure

As healthcare spending rises, particularly in emerging economies and developed countries, there is a corresponding increase in access to specialized cardiac care procedures. This improved infrastructure enables healthcare providers to offer a wider range of treatment options to a greater number of patients. Moreover, increased healthcare spending often correlates with improvements in insurance coverage and reimbursement policies, reducing financial barriers for patients, which drives this market growth.

Restraint:

High cost

The complexity and invasiveness of the procedure are two of the primary factors contributing to the high cost of pulmonary valve replacement. These factors contribute to the overall cost of the procedure, including pre-operative assessments, post-operative care, and follow-up visits. Additionally, the materials used in pulmonary valve replacement, such as prosthetic valves or conduits, can be expensive, further driving up the cost of the procedure.

Opportunity:

Technological advancements

Advancements in prosthetic valve design and materials contribute to improved longevity, durability, and biocompatibility of pulmonary valve replacements. These innovations result in better clinical outcomes and reduced rates of valve failure, leading to increased patient satisfaction and a decreased need for repeat interventions. Furthermore, advancements in imaging technologies, such as 3D echocardiography and cardiac magnetic resonance imaging (MRI), enhance preoperative planning, which is boosting this market growth.

Threat:

Lack of awareness

Limited awareness about the symptoms and consequences of pulmonary valve conditions may lead to delays in diagnosis and intervention, resulting in poorer patient outcomes. Healthcare providers may also lack sufficient understanding of the latest advancements in techniques and technologies, leading to suboptimal patient care and the underutilization of appropriate treatments. Furthermore, patients and their families may have misconceptions or fears about surgical procedures, which can impede this market size.

Covid-19 Impact

The COVID-19 pandemic has significantly impacted the pulmonary valve replacement market. As healthcare systems worldwide diverted resources to manage the pandemic, elective procedures, including pulmonary valve replacements, experienced delays and cancellations. This led to a reduction in procedural volumes and revenue for manufacturers and healthcare facilities specializing in cardiac interventions. Moreover, patient reluctance to seek non-urgent medical care due to fear of exposure to the virus further dampened demand for pulmonary valve replacement procedures.

The tissue engineered pulmonary valves segment is expected to be the largest during the forecast period

The tissue engineered pulmonary valves segment is estimated to hold the largest share. These valves are designed to mimic the structure and function of native pulmonary valves, offering promising solutions for patients with pulmonary valve dysfunction. Tissue-engineered pulmonary valves are typically created by seeding cells onto a biodegradable scaffold, allowing for the growth of living tissue. Additionally, tissue-engineered valves have shown promising outcomes in terms of long-term functionality and hemodynamic performance, which gradually boosts this segment's growth.

The transcatheter pulmonary valve replacement (TPVR) segment is expected to have the highest CAGR during the forecast period

The transcatheter pulmonary valve replacement (TPVR) segment is anticipated to have highest CAGR during the forecast period due to its minimally invasive procedure for replacing pulmonary valves via catheterization. This approach is particularly beneficial for patients with congenital heart defects, pulmonary valve stenosis, or regurgitation. Furthermore, TPVR procedures have demonstrated excellent outcomes in terms of safety, efficacy, and patient recovery, compared to traditional surgical interventions, which are driving this segment's expansion.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to a growing prevalence of congenital heart diseases and valve disorders. This region is home to some of the major players, such as Medtronic, Abbott Laboratories, and Boston Scientific. Moreover, government initiatives aimed at improving cardiovascular healthcare and advancing medical research also play a vital role in fueling market growth.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to significant advancements in medical technology, robust healthcare systems. Countries like Germany, France, the United Kingdom, and Italy are key contributors to the market's growth in the region. Additionally, Europe has a strong regulatory framework supporting medical innovation, ensuring the safety and efficacy of new pulmonary valve replacement technologies, fostering competition, and driving advancements in the field.

Key players in the market

Some of the key players in the Pulmonary Valve Replacement Market include Edwards Lifesciences, Medtronic, Terumo Corporation, CryoLife, Inc, SynCardia Systems, Inc., Abbott Laboratories, Merit Medical Systems, LivaNova PLC, Micro Interventional Devices, Inc., Boston Scientific, Braile Biomedica, JenaValve Technology, Inc., B. Braun Melsungen AG, Medistim and CardioMech AS.

Key Developments:

In January 2024, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Axonics, Inc., a publicly traded medical technology company primarily focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction.

In December 2023, Medtronic plc announced that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals.

In November 2023, Medtronic plc announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral(TM) renal denervation (RDN) system, also known as the Symplicity(TM) blood pressure procedure, for the treatment of hypertension.

In September 2023, Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval for the latest-generation WATCHMAN FLX(TM) Pro Left Atrial Appendage Closure (LAAC) Device.

Valve Types Covered:

  • Tissue Engineered Pulmonary Valves
  • Bioprosthetic Pulmonary Valves
  • Homograft Pulmonary Valves
  • Mechanical Pulmonary Valves
  • Other Valve Types

Procedure Types Covered:

  • Transcatheter Pulmonary Valve Replacement (TPVR)
  • Surgical Pulmonary Valve Replacement (Open-heart surgery)
  • Robotic-Assisted Pulmonary Valve Replacement
  • Ross Procedure
  • Valvulotomy
  • Other Procedure Types

Applications Covered:

  • Pulmonary Stenosis
  • Valve Dysfunction
  • Congenital Heart Defects
  • Pulmonary Regurgitation
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Cardiac Specialty Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pulmonary Valve Replacement Market, By Valve Type

  • 5.1 Introduction
  • 5.2 Tissue Engineered Pulmonary Valves
  • 5.3 Bioprosthetic Pulmonary Valves
  • 5.4 Homograft Pulmonary Valves
  • 5.5 Mechanical Pulmonary Valves
  • 5.6 Other Valve Types

6 Global Pulmonary Valve Replacement Market, By Procedure Type

  • 6.1 Introduction
  • 6.2 Transcatheter Pulmonary Valve Replacement (TPVR)
  • 6.3 Surgical Pulmonary Valve Replacement (Open-heart surgery)
  • 6.4 Robotic-Assisted Pulmonary Valve Replacement
  • 6.5 Ross Procedure
  • 6.6 Valvulotomy
  • 6.7 Other Procedure Types

7 Global Pulmonary Valve Replacement Market, By Application

  • 7.1 Introduction
  • 7.2 Pulmonary Stenosis
  • 7.3 Valve Dysfunction
  • 7.4 Congenital Heart Defects
  • 7.5 Pulmonary Regurgitation
  • 7.6 Other Applications

8 Global Pulmonary Valve Replacement Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals
  • 8.4 Cardiac Specialty Clinics
  • 8.5 Other End Users

9 Global Pulmonary Valve Replacement Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Edwards Lifesciences
  • 11.2 Medtronic
  • 11.3 Terumo Corporation
  • 11.4 CryoLife, Inc
  • 11.5 SynCardia Systems, Inc.
  • 11.6 Abbott Laboratories
  • 11.7 Merit Medical Systems
  • 11.8 LivaNova PLC
  • 11.9 Micro Interventional Devices, Inc.
  • 11.10 Boston Scientific
  • 11.11 Braile Biomedica
  • 11.12 JenaValve Technology, Inc.
  • 11.13 B. Braun Melsungen AG
  • 11.14 Medistim
  • 11.15 CardioMech AS

List of Tables

  • Table 1 Global Pulmonary Valve Replacement Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 3 Global Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 4 Global Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 5 Global Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 6 Global Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 7 Global Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 8 Global Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 9 Global Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 10 Global Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 11 Global Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 12 Global Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 13 Global Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 14 Global Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 15 Global Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 16 Global Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 17 Global Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 18 Global Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 19 Global Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 20 Global Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 21 Global Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 Global Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 23 Global Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 24 Global Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 25 Global Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 26 North America Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 27 North America Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 28 North America Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 29 North America Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 30 North America Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 31 North America Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 32 North America Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 33 North America Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 34 North America Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 35 North America Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 36 North America Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 37 North America Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 38 North America Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 39 North America Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 40 North America Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 41 North America Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 42 North America Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 43 North America Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 44 North America Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 45 North America Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 46 North America Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 47 North America Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 48 North America Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 49 North America Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 50 North America Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 51 Europe Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 52 Europe Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 53 Europe Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 54 Europe Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 55 Europe Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 56 Europe Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 57 Europe Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 58 Europe Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 59 Europe Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 60 Europe Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 61 Europe Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 62 Europe Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 63 Europe Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 64 Europe Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 65 Europe Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 66 Europe Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 67 Europe Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 68 Europe Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 69 Europe Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 70 Europe Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 71 Europe Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 72 Europe Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 73 Europe Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 74 Europe Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 75 Europe Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 76 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 77 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 78 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 79 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 80 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 81 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 82 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 83 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 84 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 85 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 86 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 87 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 88 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 89 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 90 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 91 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 92 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 93 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 94 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 95 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 96 Asia Pacific Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 97 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 98 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 99 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 100 Asia Pacific Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 101 South America Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 South America Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 103 South America Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 104 South America Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 105 South America Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 106 South America Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 107 South America Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 108 South America Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 109 South America Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 110 South America Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 111 South America Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 112 South America Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 113 South America Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 114 South America Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 115 South America Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 116 South America Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 117 South America Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 118 South America Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 119 South America Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 120 South America Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 121 South America Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 122 South America Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 123 South America Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 124 South America Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 125 South America Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 126 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Country (2021-2030) ($MN)
  • Table 127 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valve Type (2021-2030) ($MN)
  • Table 128 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Tissue Engineered Pulmonary Valves (2021-2030) ($MN)
  • Table 129 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Bioprosthetic Pulmonary Valves (2021-2030) ($MN)
  • Table 130 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Homograft Pulmonary Valves (2021-2030) ($MN)
  • Table 131 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Mechanical Pulmonary Valves (2021-2030) ($MN)
  • Table 132 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Valve Types (2021-2030) ($MN)
  • Table 133 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 134 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Transcatheter Pulmonary Valve Replacement (TPVR) (2021-2030) ($MN)
  • Table 135 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Surgical Pulmonary Valve Replacement (Open-heart surgery) (2021-2030) ($MN)
  • Table 136 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Robotic-Assisted Pulmonary Valve Replacement (2021-2030) ($MN)
  • Table 137 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Ross Procedure (2021-2030) ($MN)
  • Table 138 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valvulotomy (2021-2030) ($MN)
  • Table 139 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Procedure Types (2021-2030) ($MN)
  • Table 140 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Application (2021-2030) ($MN)
  • Table 141 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Pulmonary Stenosis (2021-2030) ($MN)
  • Table 142 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Valve Dysfunction (2021-2030) ($MN)
  • Table 143 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 144 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Pulmonary Regurgitation (2021-2030) ($MN)
  • Table 145 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 146 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By End User (2021-2030) ($MN)
  • Table 147 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 148 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 149 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Cardiac Specialty Clinics (2021-2030) ($MN)
  • Table 150 Middle East & Africa Pulmonary Valve Replacement Market Outlook, By Other End Users (2021-2030) ($MN)